Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.4270
-0.0424 (-9.03%)
At close: Nov 20, 2026, 4:00 PM EST
0.4475
+0.0205 (4.80%)
After-hours: Nov 20, 2026, 7:55 PM EST
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or 29.41% compared to the previous year. That makes Curis the 37,792nd largest employer in the world and 5,349th in the United States.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$47,417
Profits / Employee
-$897,667
Market Cap
4.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -10 | -29.41% | 20 | 4 |
| Dec 31, 2024 | 34 | -15 | -30.61% | 33 | 1 |
| Dec 31, 2023 | 49 | -2 | -3.92% | 49 | 0 |
| Dec 31, 2022 | 51 | -9 | -15.00% | 51 | 0 |
| Dec 31, 2021 | 60 | 32 | 114.29% | 60 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Cardio Diagnostics Holdings | 17 |
| VivoSim Labs | 15 |
| Kiora Pharmaceuticals | 13 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
| Tempest Therapeutics | 4 |
CRIS News
- 3 days ago - Curis Transcript: EGM 2026 - Transcripts
- 8 days ago - Curis registers to sell 33.33M shares of common stock for holders - TheFly
- 8 days ago - Curis price target lowered to $5 from $20 at Jones - TheFly
- 9 days ago - Curis Registration statement: Registration filing - Filings
- 9 days ago - Curis price target lowered to $6 from $43 at H.C. Wainwright - TheFly
- 9 days ago - Curis Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Curis Earnings release: Q3 2026 - Filings
- 9 days ago - Curis Quarterly report: Q3 2026 - Filings